Literature DB >> 30109743

Current natural therapies in the treatment against glioblastoma.

José Ignacio Erices1, Ángelo Torres1, Ignacio Niechi1, Isabel Bernales1, Claudia Quezada2.   

Abstract

Glioblastoma (GBM) is the most common and aggressive brain tumor, which causes the highest number of deaths worldwide. It is a highly vascularized tumor, infiltrative, and its tumorigenic capacity is exacerbated. All these hallmarks are therapeutic targets in GBM treatment, including surgical removal followed by radiotherapy and chemotherapy. Current therapies have not been sufficient for the effective patient's management, so the classic therapies have had to expand and incorporate new alternative treatments, including natural compounds. This review summarizes natural products and their physiological effects in in vitro and in vivo models of GBM, specifically by modulating signaling pathways involved in angiogenesis, cell migration/invasion, cell viability, apoptosis, and chemoresistance. The most important aspects of natural products and their derivatives were described in relation to its antitumoral effects. As a final result, it can be obtained that within the compounds with more evidence that supports or suggests its clinical use are the cannabinoids, terpenes, and curcumin, because many have been shown to have a significant effect in decreasing the progress of GBM through known mechanisms, such as chemo-sensitization or decrease migration and cell invasion. Natural compounds emerge as promising therapies to attack the progress of GBM.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30109743     DOI: 10.1002/ptr.6170

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Validation of Enhancing Effects of Curcumin on Radiotherapy with F98/FGT Glioblastoma-Bearing Rat Model.

Authors:  Wei-Hsun Wang; Chao-Yu Shen; Yi-Chun Chien; Wen-Shin Chang; Chia-Wen Tsai; Yi-Hsien Lin; Jeng-Jong Hwang
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 2.  Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas.

Authors:  Shalini Sundramurthi Chelliah; Ervin Ashley Lourdes Paul; Muhamad Noor Alfarizal Kamarudin; Ishwar Parhar
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

Review 3.  Phytotherapy for the Treatment of Glioblastoma: A Review.

Authors:  Shan Yasin Mian; Abhishek Nambiar; Chandrasekaran Kaliaperumal
Journal:  Front Surg       Date:  2022-03-25

4.  Purple sweet potato delphinidin-3-rutin represses glioma proliferation by inducing miR-20b-5p/Atg7-dependent cytostatic autophagy.

Authors:  Meng Wang; Ke Liu; Huimin Bu; Hao Cong; Guokai Dong; Nana Xu; Changgen Li; Yunyun Zhao; Fei Jiang; Yongjing Zhang; Bo Yuan; Rongpeng Li; Jihong Jiang
Journal:  Mol Ther Oncolytics       Date:  2022-07-31       Impact factor: 6.311

Review 5.  Therapeutic effect of natural polyphenols against glioblastoma.

Authors:  Ozal Beylerli; Aferin Beilerli; Alina Shumadalova; Xiaoxiong Wang; Mingchun Yang; Hanran Sun; Lei Teng
Journal:  Front Cell Dev Biol       Date:  2022-10-04

6.  Investigating the antiangiogenic potential of Rumex vesicarius (humeidh), anticancer activity in cancer cell lines and assessment of developmental toxicity in zebrafish embryos.

Authors:  Muhammad Farooq; Nael Abutaha; Shahid Mahboob; Almohannad Baabbad; Nawaf D Almoutiri; Mohammad Ahmed A M Wadaan
Journal:  Saudi J Biol Sci       Date:  2019-12-06       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.